ResMed | RMD - Sales Revenues

Stock Price
36.20
Daily Change
0.62 1.74%
Monthly
-1.68%
Yearly
-2.48%
Q1 Forecast
35.54

ResMed reported $1.42B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
Avita Medical AUD 18.42M 14K Jun/2025
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Fisher & Paykel Healthcare NZD 1.09B 9.2M Sep/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Nanosonics AUD 105.03M 11.44M Jun/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
Regis Healthcare AUD 619.06M 37.36M Dec/2024
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.45B 470M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025